MBI's media team has the skills and relationships with national and international print, online and broadcast media to get your story told.
MBI has a seasoned investor relations team and a proven track record of building or restoring credibility with investors and analysts.
MBI brings a fresh, strategic approach to business development for its clients within the biotechnology, medical device, and life sciences industries.
MBI specializes in branding and rebranding private and public life science companies. A clear and consistent corporate identity is the keystone to a successful communications plan.
Image Building | Visual Branding
MBI understands that corporate credibility is one of the most important assets a company can build and that it is one of the hardest to repair when damaged by a crisis.
There are over 1,000 life science industry conferences scheduled around the world each year... Learn More
12/18/14 - Enumeral and Merck Form Collaboration for Predicting Clinical Drug Response with Human-driven Immune Profiling Platform
12/17/14 - Poxel Announces Positive Top Line Results for Its Antidiabetic Agent Imeglimin in a Phase 2b Dose-Ranging Trial
12/15/14 - Annexon Bioscience Closes $34M Series A-1 Funding for Novel Approach to Neurodegenerative and Autoimmune Diseases
MacDougall Biomedical Clients in San Francisco
Come and schedule meetings with our clients during the week of January 13-16, 2014